Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Pancreatic Cancer–Derived Exosomes Cause Paraneoplastic β-cell Dysfunction
2014
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Right Ventricular Function and Failure
2006
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Gas diffusion and alveolar-capillary unit in chronic heart failure
2006
Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent
1998
Microbubbles in ultrasound-triggered drug and gene delivery
2008 Standout
Clinical Outcome and Phenotypic Expression in <emph type="ital">LAMP2</emph> Cardiomyopathy
2009
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles
2007
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Cardiac rehabilitation and artificial heart devices
2009
The Failing Heart — An Engine Out of Fuel
2007 Standout
Effect of exercise training on VO2peak and left ventricular systolic function in recent cardiac transplant recipients
2005
Amyloid diseases of the heart: current and future therapies
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Litigation in Nontraumatic Aortic Diseases – A Tempest in the Malpractice Maelstrom
2007
Exercise Standards for Testing and Training
2013 Standout
Energy metabolism in heart failure
2003
Transcriptional regulation by calcium, calcineurin, and NFAT
2003 Standout
Sonochemical synthesis of nanomaterials
2012 Standout
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Serum D-Dimer is a Sensitive Test for the Detection of Acute Aortic Dissection: A Pooled Meta-Analysis
2008
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Function, Eligibility, Outcomes, and Exercise Capacity Associated With Left Ventricular Assist Devices
2003
Systemic amyloidosis
2015 Standout
Infiltrative Cardiovascular Diseases
2010
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Calcineurin Co-regulates Contractile and Metabolic Components of Slow Muscle Phenotype
2000
Surface-modified protein nanospheres as potential antiviral agents
2012
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
2002 StandoutNature
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Heart failure: a model of cardiac and skeletal muscle energetic failure
2006
Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation
2004
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
A facile one-pot sonochemical synthesis of surface-coated mannosyl protein microspheres for detection and killing of bacteria
2011
Endurance training in patients with chronic obstructive pulmonary disease: A comparison of high versus moderate intensity
2000
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Microparticles: Key Protagonists in Cardiovascular Disorders
2010
Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters
2010
Albumin-based nanoparticles as potential controlled release drug delivery systems
2011
The prognostic importance of lung function in patients admitted with heart failure
2010
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vena caval filters: a comprehensive review
2000
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia
2019
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Mitochondria express enhanced quality as well as quantity in association with aerobic fitness across recreationally active individuals up to elite athletes
2012
Water Soluble Polymers for Pharmaceutical Applications
2011
Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles
2003
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Physiological adaptations to interval training and the role of exercise intensity
2016 Standout
Covalent interlocking of glucose oxidase and peroxidase in the voids of paper: enzyme–polymer “spider webs”
2016 StandoutNobel
Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure
2009
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection
2014
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle
2005
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity
2014
Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography
2010
Works of Éric Epailly being referenced
Safety of a new transpulmonary echocontrast agent (albunex®) in repeated echocardiographic studies in patients
1997
Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality-results of a monocenter study in 141 patients
2002
Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects
2001
Effect of short-term endurance training on exercise capacity, haemodynamics and atrial natriuretic peptide secretion in heart transplant recipients
1996
Exercise training with a heart device: a hemodynamic, metabolic, and hormonal study
2001
Persistent Exercise Intolerance Following Cardiac Transplantation Despite Normal Oxygen Transport
1996
Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients
1993
Endothelial Cell Activation Contributes to the Release of Procoagulant Microparticles During Acute Cardiac Allograft Rejection
2008
Novel Lamp‐2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease
2005
Exercise-Induced Increase in Circulating Adrenomedullin Is Related to Mean Blood Pressure in Heart Transplant Recipients
2000
Late complication of a Greenfield filter associating caudal migration and perforation of the abdominal aorta by a ruptured strut
1995
Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection
2006
Heart transplantation in systemic (AL) amyloidosis: A retrospective study of eight French patients
2008
Lung membrane diffusing capacity, heart failure, and heart transplantation
1999
Is a prosthetic ring required for mitral repair of mitral insufficiency due to posterior leaflet prolapse? Long-term results in 96 patients submitted to repair with no ring1
1998
Physical fitness after cardiac transplantation: a proposal for an endurance training program and its assessment
1992
[Suspicion of asthma due to dobutamine chlorhydrate. Apropos of a case].
1994